Ku GY - Search Results

1

Nanoliposomal irinotecan with fluorouracil for the treatment of advanced pancreatic cancer, a single institution experience.

Glassman DC, Palmaira RL, Covington CM, Desai AM, Ku GY, Li J, Harding JJ, Varghese AM, O'Reilly EM, Yu KH. Glassman DC, et al. Among authors: ku gy. BMC Cancer. 2018 Jun 27;18(1):693. doi: 10.1186/s12885-018-4605-1. BMC Cancer. 2018. PMID: 29945562 Free PMC article. Clinical Trial.

2

A dramatic response to long-acting octreotide in metastatic hepatocellular carcinoma.

Deming DA, Stella AL, Holen KD, Ku G, O'Reilly EM. Deming DA, et al. Clin Adv Hematol Oncol. 2005 Jun;3(6):468-72; discussion 472-4. Clin Adv Hematol Oncol. 2005. PMID: 16167024 No abstract available.

3

Esophageal cancer: adjuvant therapy.

Ku GY, Ilson DH. Ku GY, et al. Cancer J. 2007 May-Jun;13(3):162-7. doi: 10.1097/PPO.0b013e318074dbe7. Cancer J. 2007. PMID: 17620765 Review.

4

Phase II trial of sequential paclitaxel and 1 h infusion of bryostatin-1 in patients with advanced esophageal cancer.

Ku GY, Ilson DH, Schwartz LH, Capanu M, O'Reilly E, Shah MA, Kelsen DP, Schwartz GK. Ku GY, et al. Cancer Chemother Pharmacol. 2008 Oct;62(5):875-80. doi: 10.1007/s00280-008-0677-y. Epub 2008 Feb 13. Cancer Chemother Pharmacol. 2008. PMID: 18270704 Clinical Trial.

5

Phase I study of weekly cisplatin, bolus fluorouracil and escalating doses of irinotecan in advanced solid tumors.

Ku GY, O'Reilly EM, Saltz LB, Schrag D, Maki RG, Kelsen DP, Ilson DH. Ku GY, et al. Cancer Invest. 2009 May;27(4):402-6. doi: 10.1080/07357900802406327. Cancer Invest. 2009. PMID: 19219674 Clinical Trial.

6

Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting: lymphocyte count after 2 doses correlates with survival.

Ku GY, Yuan J, Page DB, Schroeder SE, Panageas KS, Carvajal RD, Chapman PB, Schwartz GK, Allison JP, Wolchok JD. Ku GY, et al. Cancer. 2010 Apr 1;116(7):1767-75. doi: 10.1002/cncr.24951. Cancer. 2010. PMID: 20143434 Free PMC article.

7

Phase 2 trial of induction and concurrent chemoradiotherapy with weekly irinotecan and cisplatin followed by surgery for esophageal cancer.

Ilson DH, Minsky BD, Ku GY, Rusch V, Rizk N, Shah M, Kelsen DP, Capanu M, Tang L, Campbell J, Bains M. Ilson DH, et al. Among authors: ku gy. Cancer. 2012 Jun 1;118(11):2820-7. doi: 10.1002/cncr.26591. Epub 2011 Oct 11. Cancer. 2012. PMID: 21990000 Free article. Clinical Trial.

8

Phase II trial of cetuximab plus cisplatin and irinotecan in patients with cisplatin and irinotecan-refractory metastatic esophagogastric cancer.

Janjigian YY, Ku GY, Campbell JC, Shah MA, Capanu M, Kelsen DP, Ilson DH. Janjigian YY, et al. Among authors: ku gy. Am J Clin Oncol. 2014 Apr;37(2):126-30. doi: 10.1097/COC.0b013e318271b14f. Am J Clin Oncol. 2014. PMID: 23211227 Clinical Trial.

9

Prognostic significance of PET assessment of metabolic response to therapy in oesophageal squamous cell carcinoma.

Chhabra A, Ong LT, Kuk D, Ku G, Ilson D, Janjigian YY, Wu A, Schöder H, Goodman KA. Chhabra A, et al. Br J Cancer. 2015 Dec 22;113(12):1658-65. doi: 10.1038/bjc.2015.416. Epub 2015 Dec 10. Br J Cancer. 2015. PMID: 26657654 Free PMC article.

10

Change in chemotherapy during concurrent radiation followed by surgery after a suboptimal positron emission tomography response to induction chemotherapy improves outcomes for locally advanced esophageal adenocarcinoma.

Ku GY, Kriplani A, Janjigian YY, Kelsen DP, Rusch VW, Bains M, Chou J, Capanu M, Wu AJ, Goodman KA, Ilson DH. Ku GY, et al. Cancer. 2016 Jul 1;122(13):2083-90. doi: 10.1002/cncr.30028. Epub 2016 May 6. Cancer. 2016. PMID: 27152857 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

131 results

Search Page

Filters